Bio Valley, 4baseCare and Define Bio sign MoU to set up genomics CoE at AMTZ Vizag

Bio Valley, 4baseCare and Define Bio (P) Ltd. (Biobank) have signed a Memorandum of Understanding (MoU) to establish a Center of Excellence (CoE) named BioSphere for Genomics and Next-Generation Sequencing (NGS) at Andhra Pradesh MedTech Zone (AMTZ), Vizag. The partners stated that the initiative aims to support the development of India’s genomics ecosystem.

The CoE–BioSphere will work towards strengthening genomic infrastructure by enabling diagnostics, therapeutic decisions and personalised treatments. It will generate datasets reflecting India’s genetic diversity and integrate global genomic datasets. The centre will support the development of diagnostics, risk prediction models and therapies aligned with Indian genomic variations while maintaining scientific benchmarks and interoperability. It will also facilitate research collaborations among clinicians, academic institutions, industry partners and data-based start-ups, and serve as a platform to train scientists and entrepreneurs in data-driven research and product development.

At a national level, population-scale genomic insights from the centre are expected to contribute to public health policy and preventive strategies, with a focus on accessibility, affordability and long-term impact on healthcare in India.

Hitesh Goswami, CEO and Co-founder of 4baseCare, said, “This collaboration with Bio Valley, 4baseCare and Define Bio represents a significant step in strengthening India’s innovation-led Biotech ecosystem at AMTZ. By bringing together advanced genomics expertise, incubation support, and translational research capabilities, we aim to accelerate the development of impactful precision medicine solutions. Partnerships like these reinforce our commitment to nurturing cutting-edge healthcare innovation from Andhra Pradesh and enabling globally relevant breakthroughs from India.”

The initiative includes the creation of an incubation centre within CoE–BioSphere to support genomics-based start-ups. The centre will provide sequencing services, access to data and mentorship for product development. The partners stated that CoE–BioSphere will function as a hub for genomics-driven healthcare and biotechnology developments at AMTZ.

Dr K. Suseela Branham, CEO, Bio Valley, said, “Building India’s Next-Generation Genomic Ecosystem: This strategic partnership advances data-driven precision Healthcare solutions and Genomic innovation, marking a major achievement for personalized Medical solutions in India.”